With the incorporation of the company in 2004, MAXMED made its mark in the manufacturing sector of the Indian Pharmaceuticals Industry with its high quality and affordable products. The company today boasts 3 state of the art manufacturing plants in Rudrapur (Uttarakhand), India, equipped with the latest machinery and equipment assisting in effective production. Maxmed’s YoY growth has helped the company multiply its client base and market presence. With the support of a highly experienced staff, in-house QA and QC laboratories, the company has been able to continuously provide Drugs of the highest quality and efficacy.

Over the years, MAXMED has established as one of the leading pharmaceutical manufacturing units, with wings spread across many states in India as well as explore to enter into the global market. With its strategic alliances with many international companies, MAXMED has taken an extra initiative for formulating new drugs and contract researches with the operational experts from both sides of the industry & academia. Owing to the undying dedication and zeal of MAXMED’s team, the company has carved a niche for itself with genuine and quality pharmaceutical drugs. By the virtue of the domain expertise, the company has been able to set a benchmark for profitable growth, transparency, commitment and equity in relationship.

The company strives on a well organized management which comprises skilled and highly trained professionals. The professionals have the domain expertise in pharmaceuticals and healthcare industry. They have been the key figure in new product formulation and research. To move ahead of the times MAXMED is on the constant look for the suitable alliances for investment in contract manufacturing for pharmaceuticals. Overseas mergers and collaborations to further strengthen our roots in the global market are always welcomed.


  • Export Markets (Regulated & Semi – Regulated)
  • Third Party Manufacturing / P2P Business
  • Loan License Manufacturing
  • Marketed by arrangement
  • Capacities

  • Cephalosporin / Betalactam – Dry Powder Injections: 3,00,000 Vials/day
  • Oral Dry powder: 2,50,000 Bottles per day
  • Cephalosporin / Betalactam – Tablets: 10,00,000 per day
  • Capsules: 20 lac Capsules per day

  • Our Strength

  • Dedicated Low Rh area for Clavulanate Products
  • All drugs are manufactured as per WHO-GMP standards.
  • HVAC & AHUs.
  • Innovative & Sophisticated Packaging facilities.
  • Commitment to Excellence and Quality.
  • Cost Efficiency.
  • Flexibility of Batch Sizes.
  • Dedicated & Committed team of professionals.
  • Strong Drug Regulatory team.
  • In-house WFI , PW & Nitrogen Plant
  • In-house NABL Lab & F&D Centre
  • Trusted by some of the world's smartest partners

    Our Happy Clients

    What they say about us

    Scroll to Top